Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives

Maggie Zi Chow , Kenneth R Boheler and Ronald A Li

Stem Cell Research & Therapy 2013, 4:97 (14 August 2013)

Ronald Li and colleagues review the use of human embryonic stem cell- and induced pluripotent stem cell-derived cardiomyocytes for drug discovery and toxicity screening, disease modeling and regenerative medicine.

Subscription required

All research articles in Stem Cell Research & Therapy are open access. The journal also publishes a range of other articles that are available to subscribers.

Existing subscribers

Forgotten your password? help